{"id":"W4404275877","doi":"10.1016/j.ygyno.2024.11.004","title":"Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Ovarian cancer; Placebo; Adverse effect; Oncology; Internal medicine; Gynecology; Cancer; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002788491,0.0004106451,0.001122616,0.0002635776,0.0002336236,0.0006936385,0.0003355012,0.0006872579,0.002381255],"category_scores_gemma":[0.003796349,0.0001954247,0.001045744,0.0003169384,0.0003737071,0.0004781997,0.0003025214,0.0009138031,0.0001859772],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003566573,"about_ca_system_score_gemma":0.0005988934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002043814,"about_ca_topic_score_gemma":0.0004873387,"domain_scores_codex":[0.9985668,0.0008747582,0.0001328703,0.0001743737,0.0001725615,0.00007864786],"domain_scores_gemma":[0.9973683,0.0007680499,0.001312468,0.0001295977,0.00014901,0.0002726867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8330333,0.003000227,0.02540355,0.002479045,0.002834642,0.0001566063,0.0002159014,0.0006030131,0.009412916,0.0001788629,0.001721592,0.1209603],"study_design_scores_gemma":[0.4817563,0.3421896,0.1553158,0.0006498436,0.003981957,0.0009599578,0.0001680164,0.0022849,0.004407829,0.0008699091,0.00733843,0.00007748144],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903928,0.007269636,0.0001759263,0.0002235179,0.00006088007,0.0003928369,0.0004451374,0.00002539585,0.001013921],"genre_scores_gemma":[0.9964346,0.001411238,0.0002660406,0.0002243126,0.0001123824,0.0005053338,0.0004958254,0.000005826149,0.0005444863],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002788491,"threshold_uncertainty_score":0.01474708,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04708799353265499,"score_gpt":0.3836628542355993,"score_spread":0.3365748607029443,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}